Welcome to our dedicated page for Puretech Health SEC filings (Ticker: PRTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PureTech Health鈥檚 SEC disclosures can feel like a maze. One annual report interweaves results from wholly-owned programs, controlled founded entities, and equity stakes鈥攍eaving many investors asking, 鈥淗ow do I understand PureTech Health SEC documents with AI?鈥� If you have searched for 鈥淧ureTech Health insider trading Form 4 transactions鈥� or wondered where the 鈥淧ureTech Health quarterly earnings report 10-Q filing鈥� lives, you know the data is buried in hundreds of technical pages.
Stock Titan solves this problem. Our AI reads every PureTech Health filing the moment it hits EDGAR, then delivers plain-English summaries, red-flag alerts, and side-by-side comparables. Whether it is a PureTech Health annual report 10-K simplified, a PureTech Health 8-K material events explained, or a PureTech Health Form 4 insider transactions real-time feed, you receive the context that matters鈥擱&D spend by program, milestone revenue timing, or shifts in subsidiary ownership鈥攚ithout trawling through footnotes.
Use the platform to:
- Spot PureTech Health executive stock transactions Form 4 minutes after they post.
- Run a PureTech Health earnings report filing analysis across sequential 10-Qs to track trial costs versus cash runway.
- Review the PureTech Health proxy statement executive compensation and see how incentive targets align with pipeline milestones.
Every filing type鈥�10-K, 10-Q, 8-K, S-3, DEF 14A and more鈥攊s archived with real-time updates and AI-powered key-point extraction. Complex biotech disclosures become clear, actionable insight.
Citigroup and several of its subsidiaries report a collective beneficial ownership of 13,220,374 ordinary shares of PureTech Health plc, representing 5.5% of the class. The filing names five Citigroup reporting persons and discloses that the position carries shared voting power and shared dispositive power; no sole voting or dispositive authority is reported.
The statement indicates the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing also describes the chain of ownership among the Citigroup entities that hold the position.
FAQ
What is the current stock price of Puretech Health (PRTC)?
What is the market cap of Puretech Health (PRTC)?
